Amorfix Life Sciences Ltd. (AMF) - Medical Equipment - Deals and Alliances Profile

Date: July 3, 2015
Pages: 60
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AC8841480CDEN
Leaflet:

Download PDF Leaflet

Amorfix Life Sciences Ltd. (AMF) - Medical Equipment - Deals and Alliances Profile
Summary

Amorfix Life Sciences Ltd. (Amorfix) is a development stage biopharmaceutical company. It focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, which helps in predicting new disease specific epitopes on the molecular surface of misfolded proteins. Based on ProMIS technology, the company is developing antibody therapeutics and diagnostics targeting cancer and amyotrophic lateral sclerosis (ALS). The company developed two new technologies, namely, Epitope Protection and AMFIA for identifying low levels of misfolded proteins in the biological samples which helped in generating cerebrospinal fluid screening test for Alzheimer’s disease. The company's products and services include therapeutics, diagnostic kits, diagnostic services, and reagents. Amorfix is headquartered in Mississauga, Ontario, Canada.

As a part of its overall strategy to build its product pipeline, the company establishes partnerships and strategic alliances to accelerate the discovery, development and commercialization of its therapeutic antibodies. To this end the company recently entered into a collaboration agreement with Trellis Bioscience for developing antibodies against misfolded CD38 protein for the treatment of haematological malignancies such as leukemia and lymphoma.

Amorfix Life Sciences Ltd. (AMF) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Amorfix Life Sciences Ltd., Medical Equipment, Deals By Year, 2009 to YTD 2015
Amorfix Life Sciences Ltd., Medical Equipment Deals By Type, 2009 to YTD 2015
Amorfix Life Sciences Ltd., Medical Equipment, Deals By Region, 2009 to YTD 2015
Amorfix Life Sciences Ltd., Medical Equipment, Deals By Market, 2009 to YTD 2015
Amorfix Life Sciences Ltd., Medical Equipment, Deals Summary, 2009 to YTD 2015
Amorfix Life Sciences Ltd., Medical Equipment, Deal Details
Partnerships
Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences
Amorfix Life Sciences Enters Into Co-Development Agreement With Trellis Bioscience
Amorfix Life Sciences Enters Into Agreement With Pharma Company For Alzheimer's Disease Diagnostic
Amorfix Life Sciences Enters Into Co-Development Agreement With QPS Holdings
Amorfix Life Sciences Enters Into An Agreement With BioMosaics
Equity Offering
Amorfix Life Sciences to Raise up to USD2 Million in Private Placement of Shares
Amorfix Life Sciences Completes Third Tranche Of Private Placement Of Shares And Warrants For US$1 Million
Amorfix Life Sciences Completes Private Placement Of Securities For US$0.4 Million
Amorfix Life Sciences Completes Private Placement Of Units For US$0.5 Million
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Shares For US$0.2 Million
Amorfix Life Sciences Completes First Tranche Of Private Placement Of Units For US$0.5 Million
Amorfix Life Sciences Completes Second And Final Tranche Of Private Placement Of Units For US$0.3 Million
Amorfix Life Sciences Completes Private Placement Of Units For US$0.2 Million
Amorfix Life Sciences Completes Private Placement Of Units For US$1 Million
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Units For US$0.08 Million
Amorfix Life Sciences Terminates Private Placement Of Units For US$2.57 Million
Amorfix Life Sciences Completes Private Placement Of US$0.51 Million
Amorfix Life Sciences Completes Private Placement Of US$2.71 Million
Amorfix Life Sciences Ltd. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Recent Developments
Strategy And Business Planning
Apr 08, 2015: Amorfix Completes Optimization of Alzheimer's Disease Diagnostic and Seeks Strategic Partner for Development and Commercialization of the Assay
Financial Announcements
May 25, 2015: Amorfix Announces Financial Results for First Quarter 2015
Mar 31, 2015: Amorfix Announces Financial Results For Nine-month Period Ended December 31, 2014
Nov 12, 2014: Amorfix announces second quarter results for period ending September 30, 2014
Aug 07, 2014: Amorfix announces fiscal 2015 first quarter results
Jun 13, 2014: Amorfix announces fiscal 2014 year end results
Feb 13, 2014: Amorfix announces fiscal 2014 third quarter results
Corporate Communications
Sep 04, 2014: Amorfix appoints Dr Elliot Goldstein and Mr Warren Whitehead to Board of Directors
Aug 20, 2014: Amorfix announces retirement of Dr. Hans Black
Jun 12, 2014: William Wyman appointed Amorfix Chairman of the Board
Mar 20, 2014: Former Amorfix Board member Walter Von Wartburg to act as Board advisor
Mar 12, 2014: Amorfix appoints Mr. William Wyman and Mr. William Copeland to Board Of Directors
Jan 24, 2014: Amorfix Announces Retirement of Walter von Wartburg
Product News
Apr 08, 2015: Amorfix Completes Optimization of Alzheimer's Disease Diagnostic and Seeks Strategic Partner for Development and Commercialization of the Assay
Jan 22, 2014: Amorfix enters into agreement with a major global pharmaceutical company for Alzheimer's disease diagnostic
Clinical Trials
Apr 08, 2015: Amorfix Completes Optimization of Alzheimer's Disease Diagnostic and Seeks Strategic Partner for Development and Commercialization of the Assay
Other Significant Developments
Mar 16, 2015: Amorfix Board authorizes exploration of strategic alternatives
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Amorfix Life Sciences Ltd., Medical Equipment, Key Facts, 2014
Amorfix Life Sciences Ltd., Medical Equipment, Deals Summary, 2009 to YTD 2015
Amorfix Life Sciences Ltd., Medical Equipment, Deals By Year, 2009 to YTD 2015
Amorfix Life Sciences Ltd., Medical Equipment Deals By Type, 2009 to YTD 2015
Amorfix Life Sciences Ltd., Medical Equipment, Deals By Region, 2009 to YTD 2015
Amorfix Life Sciences Ltd., Deals By Market, 2009 to YTD 2015
Amorfix Life Sciences Ltd., Medical Equipment, Deals Summary, 2009 to YTD 2015
Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences
Amorfix Life Sciences Enters Into Co-Development Agreement With Trellis Bioscience
Amorfix Life Sciences Enters Into Agreement With Pharma Company For Alzheimer's Disease Diagnostic
Amorfix Life Sciences Enters Into Co-Development Agreement With QPS Holdings
Amorfix Life Sciences Enters Into An Agreement With BioMosaics
Amorfix Life Sciences to Raise up to USD2 Million in Private Placement of Shares
Amorfix Life Sciences Completes Third Tranche Of Private Placement Of Shares And Warrants For US$1 Million
Amorfix Life Sciences Completes Private Placement Of Securities For US$0.4 Million
Amorfix Life Sciences Completes Private Placement Of Units For US$0.5 Million
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Shares For US$0.2 Million
Amorfix Life Sciences Completes First Tranche Of Private Placement Of Units For US$0.5 Million
Amorfix Life Sciences Completes Second And Final Tranche Of Private Placement Of Units For US$0.3 Million
Amorfix Life Sciences Completes Private Placement Of Units For US$0.2 Million
Amorfix Life Sciences Completes Private Placement Of Units For US$1 Million
Amorfix Life Sciences Completes Second Tranche Of Private Placement Of Units For US$0.08 Million
Amorfix Life Sciences Terminates Private Placement Of Units For US$2.57 Million
Amorfix Life Sciences Completes Private Placement Of US$0.51 Million
Amorfix Life Sciences Completes Private Placement Of US$2.71 Million
Amorfix Life Sciences Ltd., Key Competitors
Amorfix Life Sciences Ltd., Key Employees

LIST OF FIGURES

Amorfix Life Sciences Ltd., Medical Equipment, Deals by Type, 2009 to YTD 2015
Amorfix Life Sciences Ltd., Medical Equipment, Deals By Year, 2009 to YTD 2015
Amorfix Life Sciences Ltd., Medical Equipment, Deals By Region, 2009 to YTD 2015
Amorfix Life Sciences Ltd., Medical Equipment, Deals By Market, 2009 to YTD 2015
Amorfix Life Sciences Ltd., Medical Equipment, Deals By Year, 2009 to YTD 2015
Amorfix Life Sciences Ltd., Medical Equipment, Deals by Type, 2009 to YTD 2015
Amorfix Life Sciences Ltd., Medical Equipment, Deals By Region, 2009 to YTD 2015
Amorfix Life Sciences Ltd., Medical Equipment, Deals by Market, 2009 to YTD 2015
Skip to top


Ask Your Question

Amorfix Life Sciences Ltd. (AMF) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: